The current earnings forecast score of Ardent Health Partners Inc is 7.50, ranking 41 out of 75 in the Healthcare Providers & Services industry. The average price target is 14.75, with a high of 20.00 and a low of 10.00.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
12.150
Target Price
+13.87%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
58
Total
9
Median
10
Average
Company name
Ratings
Analysts
Ardent Health Partners Inc
ARDT
12
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Ardent Health Partners Inc's expected revenue for the next quarter?
Ardent Health Partners Inc's expected revenue is 1.59B.
What is Ardent Health Partners Inc's price target?
Analysts forecast that Ardent Health Partners Inc's price target is USD 14.75, with the highest forecast at USD 20.00 and the lowest forecast at USD 10.00.
How have Ardent Health Partners IncARDT's recent earnings per share performed?
The market expectation was USD 0.28, while Ardent Health Partners IncARDT's earnings per share (EPS) for the previous quarter was USD 0.32. EPS for the next quarter is expected at USD 0.18.
What is the analyst rating for Ardent Health Partners Inc?
Based on the ratings of Ardent Health Partners Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.